FDA Warning Letter — LACROSEE EXPRESS/BP

Case 558885 — FEI 3014544944

The FDA took a Warning Letter action against LACROSEE EXPRESS/BP on Jul 5, 2018 (La Crosse, IN). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
LACROSEE EXPRESS/BP
Date
Jul 5, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
La Crosse, IN (United States)